GMP for Clinical Trials Manufacture and Supply Training
About This Course
Keeping up with the changing legislation for clinical trials provides challenges for all those working with investigational medicinal products. This highly interactive training course teaches you all you need to know about international GMP regulations and requirements for the manufacture, control, storage and distribution of medicines to be used in clinical trials manufacture.
Using practical exercises, our clinical trial GMP training tutors help you to gain a better understanding of the ever-changing world of clinical supply and its legislation. Our tutors are a combination of ex MHRA inspectors and current IMP QPs, and teach you simple and pragmatic ways of working designed to help you better meet the needs of the regulators.
This training will be delivered as a combination of an instructor-led virtual classroom and self-paced learning online. Full details will be sent to you following registration.
This course is approved by the Royal Society of Chemistry and is suitable for its members’ continuing professional development.
Key Learning Objectives
On completion of this course, delegates will know and understand:
- The legislation and guidance around clinical trials and what is changing
- The interpretation of GMPs suitable for clinical trials
- The phases in clinical trials and how requirements change
- Auditing and control of clinical trial operations
- The areas of interface between GMP and GCP requirements and how these should be managed
- Clinical batch releases
Course Outline
Clinical Trials
- What are they?
- Phases of clinical development
EU Legislation Impacting Clinical Supplies
- Annex 13 and Clinical Trial Regulation 536/2014
- GMP Regulation 2017/1569 for IMPs
EU and FDA expectations compared Good Manufacturing Practice for Clinical Manufacture
- Risk management
- Sourcing of materials, including comparators and supply chain management
- Production and quality control of IMPs
- Documentation
- Packaging issues (labelling, blinding and product security)
- Validation (how much, how soon?)
- Assigning and extending shelf life
- Retains and returns
- Assessing “equivalence” of GMP standards
- Quality/technical agreements
Good Clinical Practice
- What is GCP?
- The GMP/GCP interface
Release Procedures and the Role of the QP
- QP responsibilities
- Two-stage release process
- Key challenges
The GMP/GCP Interface
- Issues that fall in the interface
- Audit findings in this area
Shipment to Clinical Sites
- Cold chain supplies
- Transportation
Typical Regulatory Inspection Findings
Discussion and Working Groups
A significant portion of course time is devoted to group work. Using case studies, delegates have the opportunity to put theory into practice. In addition, discussion periods (which include a course tutor panel session) provide delegates with an opportunity to obtain answers to their specific question and concerns.
Who Should Attend
The Aspiring Qualified Person
- Our training is generally considered the best available and our QPs are held in high regard in the industry
- As well as being accepted in the UK, our training courses are well known and accepted by several other EU countries including Ireland, the Netherlands, Austria, Hungary and Malta
- You are more likely to become a QP with us than with any other training provider
The Pharmaceutical Technical Professional
- Not all the people attending these courses intend to become QPs. Many use the training to develop as technical managers in other areas of pharmaceutical manufacture and control
- Many industry professionals from a range of disciplines attend the courses as part of their continuing professional development. Taken with some of our other QP modules, this course is designed to lead to postgraduate certificate, diploma and MSc qualifications
Course Tutors
Darren Jones – Darren is an ex-MHRA GMP Inspector and has audited dosage forms for both commercial and clinical trial applications. Darren also has a wealth of practical knowledge and experience applying GMP in the clinical development world gained during his 18 years with AstraZeneca, prior to joining the MHRA. He was a Qualified Person for IMPs and knows the real challenges and how to overcome them.
Richard Funnell – Richard spent 11 years with the MHRA, including seven as a Senior GMP Inspector with the lead for IMPs. Richard has current knowledge and understanding of what inspectors are looking for in the lead up to the new clinical trial regulations.
Kate Krachai – Kate has over 20 years’ experience in the pharmaceutical industry as a proactive quality manager and pharmaceutical lead auditor, working to enrich quality systems and compliance with companies of varying sizes globally.
Discounts
Multi-delegate discounts available. Discounts also offered to NHS staff and charities.
Pharmaceutical Quality Systems
Pharmaceutical Law and Administration
The Role and Professional Duties of the Qualified Person
Additional Recommended Courses
CQI & IRCA-certified QMS Lead Auditor based on ISO 13485:2016 and MDSAP Requirements
This virtual instructor-led CQI/IRCA accredited course provides learners with the skills and knowledge that have taken many experienced auditors decades to develop. This course is fundamental to achieving CQI/IRCA Lead Auditor status. During the course, learners will plan, perform, and report audits based on case studies that simulate internal, supplier, and third-party audits utilizing MDSAP audit criteria. Learners will participate in simulated auditing exercises that include planning and performing audit activities, evaluating audit evidence, and documenting audit findings.
The course consists of five days of interactive instruction and auditing sessions followed by a comprehensive written examination on day six. Learners will have two hours to complete the exam, which is provided and proctored in a virtual format (additional time will be added for non-native English-speaking learners, and learners with disabilities).
Learners should enter the QMS Lead Auditor course with a basic understanding of ISO 13485:2016. Mandatory prerequisite reading and a prerequisite competency assessment will be provided upon enrollment. These prerequisites must be completed in advance of the course start date.
Ask about our discount pricing when bundling courses together. We can also bring this course to your individual organization through virtual instructor-led or face-to-face training.
This class is helpful for all personnel involved in preparing, conducting, managing, participating in, or otherwise facilitating internal, supplier, or regulatory audits and their outcomes, as well as executive personnel with responsibility for the design and implementation of any aspect of a quality management system.
By the end of this course you should be able to:
· Describe the purpose of:
- Quality management systems
- Quality management system standards
- Management system audits
- Third-party certification
· Explain the role of an auditor to plan, conduct, report and follow up a quality management system audit in accordance with ISO 19011:2018
· Plan, conduct, report and follow up an audit of a quality management system to establish conformity (or otherwise) with ISO 13485:2016 and MDSAP participating country-specific requirements.
Price: $2800.00
MDSAP Internal Auditor Training
This virtual instructor-led course was designed and developed by the Medical Device Single Audit Program (MDSAP) Lead Project Manager responsible for the team that designed, implemented, and maintained the MDSAP program.
This training focuses internal auditors on the applicable MDSAP country-specific requirements that are applicable to the auditee organization. This focus, when used in conjunction with an existing ISO 13485 internal audit program, will provide the comprehensive coverage necessary to assure all applicable MDSAP regulatory requirements are audited. In addition, resources and insight into how MDSAP Auditing Organizations establish competence of their auditors will be discussed.
An “MDSAP Lite” audit tool will be provided including country-specific requirements and hyperlinks to the specific regulatory requirements (audit criteria) relative to each country-specific requirement. Through expertly designed individual and group tasks and activities, learners will demonstrate how to identify applicable country-specific requirements, how to plan the time necessary to conduct the audit of applicable country-specific requirements, how to plan an MDSAP Lite audit, as well as how to identity, document, and grade country-specific nonconformities.
This training is essential to anyone engaged in planning or conducting internal audits of an organization participating in MDSAP.
Ask about our discount pricing when bundling courses together. We can also bring this course to your individual organization through virtual instructor-led or face-to-face training.
By the end of this training you should be able to:
- Describe an MDSAP Audit and identify criteria used during an MDSAP Audit
- Recognize International Medical Device Regulators Forum (IMDRF) governing procedures relative to MDSAP Auditing Organizations
- Recognize the competency and training requirements for AO auditors
- Recognize the structure and utility of the “MDSAP Lite” internal audit approach and “Toolkit”
- Calculate audit time and plan an MDSAP Lite internal audit
- Identify nonconformities, write nonconformity (NC) statements, and support the nonconformity statements with audit evidence
- Identify post-audit MDSAP activities including NC grading
- Recognize the outcomes and goals of an MDSAP audit
Price: $1200.00
EU IVDR Internal Auditor
This virtual instructor-led two-day course provides guidance on how to prepare for, plan, and conduct an internal or supplier audit based on the EU IVDR. This course also focuses on ISO 13485:2016 relative to its correspondence with the EU IVDR.
This course provides practical instruction for auditors and managers performing, facilitating, or managing internal and supplier audits against criteria contained within the European Union In Vitro Diagnostic Regulation (EU IVDR). The instructor will review the regulation in depth from the auditor’s perspective and provide practical instruction for preparing for, planning and conducting EU IVDR audits according to NSF’s formal, documented EU IVDR Audit Model.
This course includes a two-hour eLearning prerequisite module, EU IVDR – A Comprehensive Overview, to be completed prior to the start of the live instruction. The self-paced eLearning covers every aspect of the regulation and identifies key pre- and post-market requirements associated with EU IVDR – standard regulatory requirements that must be met by all In Vitro Diagnostic manufacturers wishing to do business in the EU regardless of IVD classification.
Ask about our discount pricing when bundling courses together. We can also bring this course to your individual organization through virtual instructor-led or face-to-face training.
By the end of this training you should be able to:
- Identify Key Articles and Annexes of the EU IVDR
- Recognize Intent of Requirements as Described in Recitals
- Identify Classification Implementing and Classification Rules
- Identify General Safety and Performance Requirements (GSPRs)
- Recognize Content of Technical Documentation
- Identify Post-Market Surveillance Reporting and Vigilance Obligations
- Recognize one EU IVDR Audit Model
- Plan an EU IVDR Audit
- Document Nonconformities against EU IVDR requirements
Who should attend:
This course is helpful for experienced internal auditors seeking to expand their auditing knowledge of the EU IVDR, for managers of audit programs, and for anyone who will be the subject of or participate in an EU IVDR audit. Delegates should have some internal audit experience and ideally have certified auditor/lead auditor qualifications in QMS audits.
Price: $1200.00